MarketCap
Facebook
X
TelegramQuarterly report 2026-Q1
added 05-23-2026
Bausch Health Companies DIO Ratio 2011-2026 | BHC
Annual DIO Ratio Bausch Health Companies
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | - | - | 172 | 145 | 150 | 148 | 177 | 154 | 169 | 187 | 178 | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 187 | 145 | 165 |
DIO Ratio of other stocks in the Drug manufacturers industry
| Issuer | DIO Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Endo International plc
ENDP
|
100 | - | - | $ 28.9 M |  Irlanda |
 |
Evoke Pharma
EVOK
|
995 | - | - | $ 36.6 M |  USA |
 |
HEXO Corp.
HEXO
|
703 | - | 2.45 % | $ 38.1 M |  Canada |
 |
AcelRx Pharmaceuticals
ACRX
|
30.8 | - | 7.5 % | $ 6.35 M | USA |
 |
DURECT Corporation
DRRX
|
557 | - | - | $ 50.1 M | USA |
 |
Adamis Pharmaceuticals Corporation
ADMP
|
48.9 | - | 0.86 % | $ 117 M | USA |
 |
Aerie Pharmaceuticals
AERI
|
459 | - | - | $ 754 M | USA |
 |
Cumberland Pharmaceuticals
CPIX
|
280 | $ 6.15 | 2.84 % | $ 91.4 M | USA |
 |
Agile Therapeutics
AGRX
|
82.7 | - | 10.11 % | $ 58.2 M | USA |
 |
Alimera Sciences
ALIM
|
58.7 | - | - | $ 142 M | USA |
 |
Cronos Group
CRON
|
221 | $ 2.84 | - | $ 1.09 B | Canada |
 |
Athenex
ATNX
|
158 | - | -23.39 % | $ 1.76 M | USA |
 |
Harrow Health
HROW
|
65.1 | $ 35.21 | -0.51 % | $ 1.29 B | USA |
 |
Avadel Pharmaceuticals plc
AVDL
|
366 | - | - | $ 2.06 B |  France |
 |
Catalent
CTLT
|
71.9 | - | - | $ 11.5 B | USA |
 |
Eagle Pharmaceuticals
EGRX
|
149 | - | -39.89 % | $ 27.7 M | USA |
 |
Pacira BioSciences
PCRX
|
246 | $ 23.22 | -1.94 % | $ 1.07 B | USA |
 |
Organogenesis Holdings
ORGO
|
85.9 | $ 2.57 | -1.91 % | $ 326 M | USA |
 |
Canopy Growth Corporation
CGC
|
167 | $ 1.09 | -2.68 % | $ 117 M | Canada |
 |
Aurora Cannabis
ACB
|
1.35 K | $ 3.6 | -1.91 % | $ 197 M | Canada |
 |
Sonoma Pharmaceuticals
SNOA
|
117 | $ 1.14 | 2.7 % | $ 1.41 M | USA |
 |
Jupiter Wellness
JUPW
|
80.2 | - | - | $ 33.6 M | USA |
 |
Tilray
TLRY
|
170 | $ 5.51 | -2.48 % | $ 3.41 B | Canada |
 |
Lannett Company
LCI
|
127 | - | 1.15 % | $ 7.11 M | USA |
 |
OrganiGram Holdings
OGI
|
2.83 K | $ 1.14 | - | $ 109 M | Canada |
 |
Evolus
EOLS
|
71.3 | $ 6.56 | -0.15 % | $ 423 M | USA |
 |
Emergent BioSolutions
EBS
|
367 | $ 9.12 | -0.65 % | $ 488 M | USA |
 |
cbdMD
YCBD
|
138 | $ 0.79 | -4.12 % | $ 3.18 M | USA |
 |
Veru
VERU
|
179 | $ 2.37 | 2.16 % | $ 34.7 M | USA |
 |
Assertio Holdings
ASRT
|
322 | $ 23.44 | - | $ 150 M | USA |
 |
ProPhase Labs
PRPH
|
30.1 | - | - | $ 5.07 M | USA |
 |
Radius Health
RDUS
|
204 | - | - | $ 1.42 B | USA |
 |
PetIQ
PETQ
|
64.9 | - | 1.64 % | $ 400 M | USA |
 |
Recro Pharma
REPH
|
49.1 | - | -4.76 % | $ 65.3 M | USA |
 |
OptiNose
OPTN
|
370 | - | - | $ 1.08 B | USA |
 |
PLx Pharma
PLXP
|
98.8 | - | -27.8 % | $ 2.56 M | USA |
 |
Viatris
VTRS
|
154 | $ 16.26 | 0.93 % | $ 18.9 B | USA |
 |
Zomedica Corp.
ZOM
|
187 | - | -0.21 % | $ 98 M | USA |
 |
Rockwell Medical
RMTI
|
29.2 | $ 0.74 | -1.8 % | $ 26.6 M | USA |
 |
China Pharma Holdings
CPHI
|
166 | $ 0.79 | 3.81 % | $ 3.39 M |  China |
 |
TherapeuticsMD
TXMD
|
1.04 K | $ 2.14 | 1.42 % | $ 24.8 M | USA |